The historical rank and industry rank for MyMD Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:
During the past 4 years, MyMD Pharmaceuticals's highest Price to Tangible Book Ratio was 642.86. The lowest was 5.73. And the median was 15.09.
MYMD's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.78 * Ranked among companies with meaningful Price-to-Tangible-Book only.
MyMD Pharmaceuticals Price-to-Tangible-Book Historical Data
The historical data trend for MyMD Pharmaceuticals's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MyMD Pharmaceuticals's Price-to-Tangible-Book
For the Biotechnology subindustry, MyMD Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MyMD Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MyMD Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where MyMD Pharmaceuticals's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
MyMD Pharmaceuticals Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of MyMD Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
MyMD Pharmaceuticals (MyMD Pharmaceuticals) Business Description
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-1R is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and a monoamine oxidase enzyme type B.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MYMD has been successfully added to your 